[go: up one dir, main page]

MA39468B1 - Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave - Google Patents

Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave

Info

Publication number
MA39468B1
MA39468B1 MA39468A MA39468A MA39468B1 MA 39468 B1 MA39468 B1 MA 39468B1 MA 39468 A MA39468 A MA 39468A MA 39468 A MA39468 A MA 39468A MA 39468 B1 MA39468 B1 MA 39468B1
Authority
MA
Morocco
Prior art keywords
agave
energy drinks
nutritional additives
spirits
based spirits
Prior art date
Application number
MA39468A
Other languages
English (en)
Other versions
MA39468A (fr
Inventor
Robert W Brocia
Original Assignee
Roar Holding Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roar Holding Llc filed Critical Roar Holding Llc
Publication of MA39468A publication Critical patent/MA39468A/fr
Publication of MA39468B1 publication Critical patent/MA39468B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12H—PASTEURISATION, STERILISATION, PRESERVATION, PURIFICATION, CLARIFICATION OR AGEING OF ALCOHOLIC BEVERAGES; METHODS FOR ALTERING THE ALCOHOL CONTENT OF FERMENTED SOLUTIONS OR ALCOHOLIC BEVERAGES
    • C12H3/00—Methods for reducing the alcohol content of fermented solutions or alcoholic beverage to obtain low alcohol or non-alcoholic beverages
    • C12H3/04—Methods for reducing the alcohol content of fermented solutions or alcoholic beverage to obtain low alcohol or non-alcoholic beverages using semi-permeable membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02—Food
    • G01N33/14—Beverages
    • G01N33/146—Beverages containing alcohol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
    • G01N2333/90605—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4)
    • G01N2333/90633—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general
    • G01N2333/90638—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general with a definite EC number (1.4.3.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)

Abstract

L'invention concerne des compositions contenant des inhibiteurs de la monoamine oxydase préparées par élimination de l'alcool présent dans des boissons issues de l'agave.
MA39468A 2014-09-16 2015-09-16 Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave MA39468B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462071179P 2014-09-16 2014-09-16
US201562231592P 2015-07-10 2015-07-10
PCT/US2015/050509 WO2016044473A1 (fr) 2014-09-16 2015-09-16 Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave

Publications (2)

Publication Number Publication Date
MA39468A MA39468A (fr) 2017-07-26
MA39468B1 true MA39468B1 (fr) 2020-09-30

Family

ID=55453705

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39468A MA39468B1 (fr) 2014-09-16 2015-09-16 Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave

Country Status (24)

Country Link
US (3) US10195163B2 (fr)
EP (1) EP3194557B1 (fr)
JP (3) JP6687626B2 (fr)
KR (1) KR102751943B1 (fr)
CN (1) CN107250340B (fr)
AU (3) AU2015317751B2 (fr)
BR (1) BR112017005328B1 (fr)
CA (1) CA2961608C (fr)
CY (1) CY1123421T1 (fr)
DK (1) DK3194557T3 (fr)
ES (1) ES2818097T3 (fr)
HR (1) HRP20201466T1 (fr)
HU (1) HUE051469T2 (fr)
LT (1) LT3194557T (fr)
MA (1) MA39468B1 (fr)
MX (1) MX2017003554A (fr)
PL (1) PL3194557T3 (fr)
PT (1) PT3194557T (fr)
RS (1) RS60851B1 (fr)
RU (1) RU2742610C2 (fr)
SI (1) SI3194557T1 (fr)
SM (1) SMT202000520T1 (fr)
WO (1) WO2016044473A1 (fr)
ZA (1) ZA201702165B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016044473A1 (fr) 2014-09-16 2016-03-24 Robert Brocia Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave
JP7244433B2 (ja) * 2017-04-05 2023-03-22 ロアー ホールディング エルエルシー テキーラまたは他の蒸留アガベ発酵製品からのｍａｏ阻害剤の改善された分離方法
CN109370848B (zh) * 2018-11-05 2022-03-15 福建农林大学 一种红曲龙舌兰酒的加工方法
MX2021006062A (es) * 2018-11-26 2021-07-06 Roar Holding Llc Metodos para mejorar la calidad de las bebidas.
US11839622B1 (en) 2020-01-15 2023-12-12 Randall Lewarchik Consumable nutraceutical composition

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6091997A (ja) * 1983-10-22 1985-05-23 Wako Pure Chem Ind Ltd モノアミンオキシダ−ゼ活性の測定方法
US4612196A (en) * 1984-08-23 1986-09-16 Miller Brewing Company Preparation of low alcohol beverages by reverse osmosis
JPS61250865A (ja) 1985-04-29 1986-11-07 Sony Corp 記録再生装置
US4933198A (en) 1985-10-11 1990-06-12 Lee Eric K L Production of low-ethanol beverage by membrane extraction
US4990350A (en) 1990-01-16 1991-02-05 Joseph E. Seagrams And Sons, Inc. Process for preparing reduced alcoholic spirits and the product produced therefrom
US5262162A (en) 1991-09-06 1993-11-16 Merz & Co. Gmbh & Co. Cerebral-activating extract
FR2715155B1 (fr) 1994-01-19 1996-07-26 Mayoly Spindler Inhibiteurs de la monoamine oxydase B et leurs procédés de préparation.
US6506430B1 (en) * 1995-07-21 2003-01-14 Brown-Forman Corporation Oak aged alcoholic beverage extract and accelerated whisky maturation method
US20050245612A1 (en) 2004-05-03 2005-11-03 Blass John P Pharmaceutical compositions for metabolic insufficiencies
EP1066033B1 (fr) 1998-03-26 2005-12-28 Phytopharm Plc Smilagenine et anzurogenine d et leur utilisation
CA2334186A1 (fr) 1998-06-05 1999-12-09 Regent Court Technologies Inhibiteurs de monoamine oxydase (mao) et leurs utilisations
JP4319735B2 (ja) 1999-03-12 2009-08-26 丸善製薬株式会社 モノアミンオキシダーゼ阻害剤および飲食物
NZ563183A (en) 2002-03-27 2009-03-31 Phytopharm Plc Therapeutic methods and uses of sapogenins and their derivatives
EP1925214A1 (fr) 2006-11-24 2008-05-28 DSMIP Assets B.V. Composition diététique ou pharmaceutique contenant cu carnosol et/ou du rosmanol
US20110067123A1 (en) 2008-02-19 2011-03-17 Julie Andersen Mao-b elevation as an early parkinson's disease biomarker
BRPI0801239A2 (pt) * 2008-04-01 2009-11-17 Ache Lab Farmaceuticos Sa uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase
US20100178411A1 (en) 2009-01-13 2010-07-15 Alma Imports, Inc. Agave-plant-based composition of matter and methods of use
US8658236B2 (en) 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
HUE044304T2 (hu) * 2010-06-18 2019-10-28 Butamax Tm Advanced Biofuels Olajból nyert oldószerek kivonása alkoholeltávolításra extraháló fermentációban
KR101111702B1 (ko) 2011-03-23 2012-02-14 최중인 역삼투화 방식의 해수 담수화 시스템 제어 방법
EP2674399B1 (fr) 2012-06-13 2014-05-14 Manfred Völker Dispositif de génération d'eau pure selon le principe d'osmose inverse
CA2783847C (fr) 2012-07-24 2014-09-30 Luc Hobson Boisson ou produit alimentaire a teneur reduite en calorie et procede et appareil pour fabriquer celui-ci
US8609162B2 (en) * 2012-10-04 2013-12-17 Invivo Beverages Llc Integrated neuromodulation system for mood enhancement of a living human subject
EP2922617B1 (fr) 2012-11-23 2021-01-06 Council of Scientific and Industrial Research Membrane tfc pour osmose inverse modifiée et utilisations de celle-ci
US9346350B2 (en) 2013-04-18 2016-05-24 Ford Global Technologies, Llc Flush and sub-flush protective shields to reduce exhaust soot and condensate deposition
WO2015136515A1 (fr) 2014-03-13 2015-09-17 Abital Pharma Pipelines Ltd. Procédés, compositions et dispositifs destinés au traitement des symptômes moteurs et dépressifs associés à la maladie de parkinson
US10610562B2 (en) 2014-06-10 2020-04-07 Akay Flavours & Aromatics PVT. LTD Instant water soluble bioactive dietary phytonutrients composition of spice/herb extracts and a process for its preparation
WO2016044473A1 (fr) * 2014-09-16 2016-03-24 Robert Brocia Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave
JP7244433B2 (ja) 2017-04-05 2023-03-22 ロアー ホールディング エルエルシー テキーラまたは他の蒸留アガベ発酵製品からのｍａｏ阻害剤の改善された分離方法
MX2021006062A (es) 2018-11-26 2021-07-06 Roar Holding Llc Metodos para mejorar la calidad de las bebidas.

Also Published As

Publication number Publication date
AU2021232783B2 (en) 2024-05-09
AU2021232783A1 (en) 2021-10-14
BR112017005328A2 (pt) 2017-12-12
MX2017003554A (es) 2017-06-30
KR102751943B1 (ko) 2025-01-09
RS60851B1 (sr) 2020-10-30
RU2017112984A (ru) 2018-10-17
RU2742610C2 (ru) 2021-02-09
US20160074343A1 (en) 2016-03-17
CY1123421T1 (el) 2021-12-31
AU2015317751A1 (en) 2017-05-04
SMT202000520T1 (it) 2020-11-10
US20190231717A1 (en) 2019-08-01
HUE051469T2 (hu) 2021-03-01
MA39468A (fr) 2017-07-26
LT3194557T (lt) 2020-11-25
US20220047531A1 (en) 2022-02-17
JP7212001B2 (ja) 2023-01-24
US10195163B2 (en) 2019-02-05
CA2961608A1 (fr) 2016-03-24
KR20170074863A (ko) 2017-06-30
JP2023052345A (ja) 2023-04-11
JP2017529102A (ja) 2017-10-05
ZA201702165B (en) 2018-04-25
BR112017005328B1 (pt) 2021-11-16
RU2017112984A3 (fr) 2019-09-16
AU2015317751B2 (en) 2019-11-14
HK1244834A1 (zh) 2018-08-17
EP3194557A1 (fr) 2017-07-26
NZ730510A (en) 2024-03-22
ES2818097T3 (es) 2021-04-09
US11160774B2 (en) 2021-11-02
SI3194557T1 (sl) 2020-11-30
AU2020200964A1 (en) 2020-02-27
EP3194557B1 (fr) 2020-07-01
WO2016044473A1 (fr) 2016-03-24
CN107250340B (zh) 2021-05-07
EP3194557A4 (fr) 2018-06-06
JP6687626B2 (ja) 2020-04-22
CA2961608C (fr) 2023-02-07
US12241048B2 (en) 2025-03-04
PL3194557T3 (pl) 2021-04-06
DK3194557T3 (da) 2020-09-21
JP7592761B2 (ja) 2024-12-02
PT3194557T (pt) 2020-09-21
JP2020110180A (ja) 2020-07-27
HRP20201466T1 (hr) 2021-03-05
CN107250340A (zh) 2017-10-13

Similar Documents

Publication Publication Date Title
EA201691794A1 (ru) Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
CN106536480A8 (zh) 吡咯烷‑2,5‑二酮衍生物、药物组合物及用作ido1抑制剂的方法
UA114901C2 (uk) Інгібітори асс та їх застосування
EA201691916A1 (ru) Биарильные ингибиторы киназы
MX2018007932A (es) Composiciones de inoculante estables y metodos para producir las mismas.
AU2015208932A8 (en) (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase I inhibitors
EA201892147A1 (ru) Бициклические соединения
EA201691799A1 (ru) Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
AU2017317563A8 (en) Detergent compositions comprising xanthan lyase variants I
SG10201809518QA (en) Processes of preparing a jak1 inhibitor and new forms thereto
MX2015012502A (es) Inhibidores de proteina cinasa dependiente de adn.
PH12018500408A1 (en) Bicyclic compounds as atx inhibitors
MX2021003792A (es) Inhibidores de benzoquinolina del transportador vesicular de monoaminas 2.
MX381487B (es) Ciertos inhibidores de la proteina quinasa.
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
EA201490846A1 (ru) Новые производные арилхинолина
EA201491647A1 (ru) Основанные на арилэфирах ингибиторы киназ
MA39468B1 (fr) Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave
EA201691397A1 (ru) Хинолиновые ингибиторы киназы
WO2018136437A3 (fr) Nouveaux composés utiles en tant qu'inhibteurs de l'indoléamine 2,3-dioxygénase et/ou du tryptophane dioxygénase
EA201990998A1 (ru) Фармацевтические составы и способы их получения
EA201590268A1 (ru) Ариллактамные ингибиторы киназы
AR099500A1 (es) Composición para el desmucilaginado enzimático de aceite
WO2016079110A3 (fr) Utilisation d'enzymes pour le nettoyage